Keyword: Peptides

News

Ambiopharm Breaks Ground on $28 Million Expansion

15.11.2024 -

Ambiopharm, a US-based pharmaceutical services company specializing in peptide manufacturing, recently announced the groundbreaking of a 70,000-square-foot (6,504 m2)...

News

SK Pharmteco to Expand Production in South Korea

03.10.2024 -

South Korean contract development and manufacturing organization (CDMO) SK Pharmteco announced a major expansion of its small molecule and peptide production capabilities...

News

CordenPharma Expands Early Clinical Peptide Manufacturing in Germany

07.03.2024 -

CordenPharma has commissioned new GMP capacities at its site in Frankfurt, Germany to manufacture early clinical phase peptide APIs for pharma and biotech customers. The...

News

CordenPharma Completes Upgrade of US Peptide Production Site in Colorado

06.09.2023 -

CDMO CordenPharma, a specialist in active pharmaceutical ingredients (APIs), excipients, drug products and packaging services, inaugurated an increased commercial peptide...

News

Bachem Inks $531 Million Peptides Manufacturing Deal

08.03.2023 -

Bachem, a Swiss specialist developer and manufacturer of peptides and oligonucleotides, has signed another order worth more than 500 million Swiss francs – or $531...

News

Croda Acquires South Korean Biotech Firm

08.02.2023 -

UK specialty chemicals company Croda International has agreed to buy Solus Biotech, a South Korean company specializing in ceramide and phospholipid technologies and with...

Chemistry & Life Sciences

Ensuring API Supply Capacities for Europe and Beyond

13.10.2022 -

Interview with Karl Rotthier, CEO of the Sanofi spin-off EuroAPI.

News

Bachem Buys DSM’s Sisslerfeld Site

10.10.2022 -

Swiss peptide and oligonucleotide specialist Bachem has agreed to buy an undeveloped site in Sisslerfeld from DSM. It has completed the purchase of a first plot, with...